Dynavax Technologies
DVAX67
$12.84arrow_drop_up0.07%$0.00
DVAX67
$12.84
arrow_drop_up0.07%Performance History
| Key Stats | |
|---|---|
| Open | $12.82 |
| Prev. Close | $12.83 |
| EPS | 0.15 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 12.72 | 12.84 |
| 52 Week Range | 9.74 | 15.15 |
| Ratios | |
|---|---|
| EPS | 0.15 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Dynavax Technologies (DVAX)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- CEO
- Mr. Ryan Spencer
- Headquarters
- EmeryVille
- Employees
- 351
- Exchange
- NASDAQ
Keep an eye on Dynavax Technologies
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Dynavax Technologies's (DVAX) price per share?
The current price per share for Dynavax Technologies (DVAX) is $12.84. The stock has seen a price change of $0.01 recently, indicating a 0.08% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Dynavax Technologies (DVAX)?
For Dynavax Technologies (DVAX), the 52-week high is $15.15, which is 17.99% from the current price. The 52-week low is $9.74, the current price is 31.83% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Dynavax Technologies (DVAX) a growth stock?
Dynavax Technologies (DVAX) has shown an average price growth of -5.34% over the past three years. It has received a score of 45 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Dynavax Technologies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Dynavax Technologies (DVAX) stock price performance year to date (YTD)?
As of the latest data, Dynavax Technologies (DVAX) has a year-to-date price change of -10.71%. Over the past month, the stock has experienced a price change of 2.8%. Over the last three months, the change has been 15.57%. Over the past six months, the figure is 12.63%. Looking at a longer horizon, the five-year price change stands at 99.22%.
help
Is Dynavax Technologies (DVAX) a profitable company?
Dynavax Technologies (DVAX) has a net income of -$6.39M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 78.4% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 15.24% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $232.28M, although specific revenue growth data is currently not available. The gross profit is $182.12M. Operating income is noted at -$37.03M. Furthermore, the EBITDA is $20.98M.
help
What is the market capitalization of Dynavax Technologies (DVAX)?
Dynavax Technologies (DVAX) has a market capitalization of $1.69B. The average daily trading volume is 12.82, indicating the stock's liquidity and investor engagement.